Abstract
Background A 55-year-old HIV-positive male presented with gross hematuria, proteinuria, acute azotemia, and recurrent left hip septic arthritis. Anti-glomerular basement membrane (anti-GBM) antibodies were present in the patient's serum, and eosinophils were noted in his urine. Renal biopsy revealed active crescents, with linear staining of the capillary wall for IgG consistent with anti-GBM nephritis.
Investigations Physical examination, blood and urine analyses, chest X-ray, CT imaging of the abdomen and pelvis, renal ultrasound, and renal biopsy.
Diagnosis Anti-GBM disease.
Management Owing to the presence of active HIV infection and recurrent left hip septic arthritis, a novel approach to treatment was pursued in the hope of reducing infectious consequences. The patient received steroids, intravenous immunoglobulin, rituximab, and mycophenolate mofetil.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Savige JA et al. (1994) Anti-nuclear, anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies in HIV-infected individuals. Autoimmunity 18: 205–211
Szczech LA et al. (2006) The uncertain significance of anti-glomerular basement membrane antibody among HIV-infected persons with kidney disease. Am J Kidney Dis 48: e55–e59
Monteiro EJ et al. (2006) Anti-glomerular basement membrane glomerulonephritis in an HIV positive patient: case report. Braz J Infect Dis 10: 55–58
Beaufils H et al. (1995) HIV-associated IgA nephropathy—a post-mortem study. Nephrol Dial Transplant 10: 35–38
Hsieh WS et al. (1992) Crescentic IgA nephropathy and acute renal failure in an HIV-positive patient with enteric salmonella infection. Nephrol Dial Transplant 11: 2320–2323
Katz A et al. (1992) IgA nephritis in HIV-positive patients: a new HIV-associated nephropathy? Clin Nephrol 38: 61–68
Kenouch S and Mery JP (1992) AIDS and IgA nephropathy. Nephron 61: 473
Jindal KK et al. (1991) Crescentic IgA nephropathy as a manifestation of human immune deficiency virus infection. Am J Nephrol 11: 147–150
Phelps RG and Turner AN (2000) Antiglomerular basement membrane disease and Goodpasture's syndrome. In Comprehensive Clinical Nephrology, edn 2, 331–340 (Eds Johnson RA and Feehally J) Philadelphia: Elsevier
Arzoo K et al. (2002) Treatment of refractory antibody mediated disorders with an anti-CD20 monoclonal antibody (rituximab). Ann Rheum Dis 61: 922–924
Ruggenenti P et al. (2003) Rituximab in idiopathic membranous nephropathy: a one-year prospective study. J Am Soc Nephrol 14: 1851–1857
Pescovitz MD et al. (2006) Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 354: 1961–1963
Salama AD and Pusey CD (2006) Drug insight: rituximab in renal disease and transplantation. Nat Clin Pract Nephrol 2: 221–230
O'Riordan A et al. (2005) Pulmonary renal syndrome due to anti-GBM and IgM C-ANCA disease requiring the use of novel therapeutic agents. Ren Fail 27: 791–794
Garcia-Canton C et al. (2000) Goodpasture's syndrome treated with mycophenolate mofetil. Nephrol Dial Transplant 15: 920–922
Selamet U et al. (2007) ANCA-associated vasculitis: new options beyond steroids and cytotoxic drugs. Expert Opin Investig Drugs 16: 689–703
[No authors listed] Rituxan warning (2007) FDA Consum 41: 3
Berger JR and Houff S (2006) Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab. Neurol Res 28: 299–305
Kishida S (2007) Progressive multifocal leukoencephalopathy—epidemiology, clinical pictures, diagnosis and therapy. Brain Nerve 59: 125–137
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
SC Jordan has grant support from Genentech, South San Francisco, CA, USA. Rituxan® (rituximab) is comarketed by Genentech and Biogen Idec in the US. There were no financial arrangements between the author and Genentech. The other authors declared no competing interests.’ This is taken from the online-only form
Rights and permissions
About this article
Cite this article
Wechsler, E., Yang, T., Jordan, S. et al. Anti-glomerular basement membrane disease in an HIV-infected patient. Nat Rev Nephrol 4, 167–171 (2008). https://doi.org/10.1038/ncpneph0724
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0724
This article is cited by
-
Use of rituximab as an induction therapy in anti-glomerular basement-membrane disease
BMC Nephrology (2018)
-
Rituximab bei Vaskulitiden
Der Nephrologe (2012)